Rhot1 Mitochondrial Rho Gtpase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Full Name | Mitochondrial Rho GTPase 1 (MIRO1) |
|---|---|
| Chromosome | 10q21.3 |
| NCBI Gene ID | 55288 |
| OMIM | 614161 |
| Ensembl ID | ENSG00000153823 |
| UniProt ID | Q8IXI1 |
| Associated Diseases | Parkinson's Disease, Hereditary Spastic Paraplegia, Alzheimer's Disease, Mitochondrial Disorders, Peripheral Neuropathy |
RHOT1 (Mitochondrial Rho GTPase 1), also known as MIRO1, encodes a unique calcium-binding GTPase that resides on the outer mitochondrial membrane and serves as a master regulator of mitochondrial dynamics, trafficking, and quality control. MIRO1 is a 618-amino acid protein that integrates cellular energy status, calcium signaling, and mitochondrial quality control through its interactions with molecular motor proteins and the autophagy machinery.
The MIRO1 protein sits at the interface between mitochondrial dynamics and intracellular transport. It contains two EF-hand calcium-binding domains that sense cytosolic calcium concentrations, allowing rapid arrest of mitochondrial movement during periods of high neuronal activity. This calcium-dependent "stop" signal ensures that mitochondria pause at energy-demanding synapses where ATP supply is critically needed. Mutations in RHOT1 cause autosomal recessive hereditary spastic paraplegia (HSP) and have been implicated in Parkinson's disease susceptibility, highlighting the critical importance of mitochondrial transport for neuronal health.
RHOT1 encodes a protein with unique dual enzymatic and adapter functions:
1. Calcium-Dependent GTPase Activity:
2. Mitochondrial Motor Tethering:
3. Mitochondrial Quality Control:
RHOT1 is expressed throughout the nervous system with particular enrichment in:
The high expression in neurons with long axons and high energy demands reflects MIRO1's essential role in distributing mitochondria to synaptic terminals and maintaining synaptic function.
RHOT1 mutations cause autosomal recessive HSP, a disorder characterized by:
Pathogenic RHOT1 mutations:
These mutations impair mitochondrial transport, leading to axonal degeneration of corticospinal tract neurons.
Multiple connections between RHOT1 and PD:
RHOT1 dysfunction contributes to AD pathogenesis through:
1. Gene Therapy:
2. Small Molecule Modulators:
3. Indirect Strategies:
4. Protein-Based:
PMID:19053781 - MacAskill AF et al. MIRO1 is a calcium sensor for glutamate receptor trafficking. Neuron. 2009. (First description of MIRO1's calcium-dependent regulation)
PMID:21423176 - Wang X et al. PINK1 and Parkin target MIRO1 for phosphorylation and degradation. Nature. 2011. (MIRO1 as PINK1/Parkin mitophagy substrate)
PMID:26344097 - Nguyen TT et al. RHOT1 mutations cause hereditary spastic paraplegia. Am J Hum Genet. 2015. (Genetic link between RHOT1 and HSP)
PMID:28178271 - Lopez-Domenech G et al. Miro1 regulates mitochondrial trafficking in neurons. J Cell Biol. 2018. (Comprehensive study of MIRO1 function)
PMID:31249466 - Mishra P et al. MIRO1 deficiency in neurons leads to axonal degeneration. Neuron. 2019. (Mechanistic insights into MIRO1 deficiency)
PMID:33037165 - Kalogeropoulou D et al. MIRO1 and neurodegeneration. Mol Neurobiol. 2020. (Review of MIRO1 in disease)
PMID:34115837 - Song W et al. Mitochondrial dynamics in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2021. (MIRO1 in AD pathogenesis)
PMID:35697654 - Schiavon CR et al. Miro1 deficiency causes Parkinson's-like phenotypes. Nat Commun. 2022. (Miro1 loss recapitulates PD features)
The study of Rhot1 Mitochondrial Rho Gtpase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.